Stay updated on Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a new page revision that updates the version of the page without altering study details.
    Difference
    0.1%
    Check dated 2026-07-05T11:50:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing Revision: v3.6.0, signaling a minor update to the page’s versioning or content. This does not modify study details or how the page is used.
    Difference
    0.1%
    Check dated 2026-06-28T08:40:05.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment status now shows no participant recruitment; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label formatting was updated along with a revision bump to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T17:43:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.
    Difference
    0.1%
    Check dated 2026-06-06T14:36:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' is added and the previous 'Revision: v3.5.3' is removed, indicating a maintenance update to the page's version log.
    Difference
    0.1%
    Check dated 2026-05-15T23:56:41.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s software/release revision from v3.5.2 to v3.5.3, without changing the underlying study information shown on the record.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.